Skip to main content

Table 4 Subgroup analyses: comparison of patients visiting, or not, an ophthalmologist during the past 2 years

From: Awareness and practices regarding eye diseases among patients with diabetes: a cross sectional analysis of the CoDiab-VD cohort

Visit to an ophthalmologist during the past 2 years

 

Yes (n = 280)

No (n = 42)

 
 

n

Mean (SD) or %

Mean or %

p-valuea

Age

322

66.8 (10.5)

64.7 (11.5)

0.244

Gender

322

   

 Women

 

40.0%

31.0%

0.262

 Men

 

60.0%

69.1%

 

Education

317

   

 Primary

 

14.9%

23.8%

0.172

 Secondary

 

59.6%

45.2%

 

 Tertiary

 

25.5%

31.0%

 

Type of diabetes c

322

   

 Type 1

 

15.0%

4.8%

0.153c

 Type 2

 

81.8%

92.9%

 

 Undetermined

 

3.2%

2.4%

 

Type of treatment

321

   

 Oral antidiabetic

 

37.9%

73.2%

<0.001

 Insulin or other antidiabetic injection

 

62.1%

26.8%

 

Member of the local diabetes association

321

20.1%

7.1%

0.053 c

Number of eye diseases reported

310

1.2 (1.0)

0.6 (0.6)

0.001

HbA1C valueb

174

7.3 (1.1)

6.8 (0.8)

0.313

ADDQoL global score

322

−1.5 (1.6)

−0.8 (1.1)

0.011

SF-12 PCS

312

43.5 (10.0)

44.8 (9.6)

0.440

SF-12 MCS

311

46.4 (11.1)

45.9 (10.2)

0.771

PACIC global score

316

2.8 (1.0)

2.2 (0.8)

<0.001

Stanford self-efficacy score

316

7.8 (1.6)

7.6 (1.9)

0.610

HbA1C awareness

303

91.3%

66.7%

<0.001

HbA1C checkb

262

99.2%

92.0%

0.047 c

Blood pressure measurement

315

99.3%

95.2%

0.087 c

Lipid profile

311

97.4%

95.2%

0.349 c

Diabetic foot examination

313

68.6%

45.2%

0.003

Microalbuminuria test

283

82.9%

71.1%

0.083

Influenza vaccination

314

67.7%

45.2%

0.005

  1. aP-value from t-tests or Chi2/Fisher’s exact test
  2. bAmong HbA1C-aware patients
  3. cCalculated with Fisher’s exact test